Cigna CEO David Cordani To Retire And Be Replaced By Internal Choice

Why It Matters

The leadership change ensures continuity while positioning Cigna to accelerate its shift toward commercial, technology‑focused health plans, a move critical for competing in a cost‑pressured industry.

Key Takeaways

• Cordani retires July 1; Evanko becomes CEO
• Evanko previously led Cigna Healthcare and Evernorth
• Cigna sold Medicare Advantage business to HCSC
• 2025 net income nearly $6 billion despite rising costs
• Strategy now emphasizes commercial plans, AI, and personalization

Pulse Analysis

Cigna’s leadership handoff from David Cordani to Brian Evanko marks a rare example of a seamless internal succession in the health‑insurance sector. Cordani’s 17‑year tenure saw the company grow its earnings base and navigate regulatory scrutiny, while Evanko’s three‑decade tenure across finance, operations, and the Evernorth platform equips him to steer the next phase. By retaining Cordani as board chair, Cigna signals strategic stability, reassuring investors and policy makers amid ongoing debates over health‑care affordability.

The transition coincides with Cigna’s decisive exit from the Medicare Advantage market, a segment that has been eroding profit margins for many insurers. The sale of its Medicare business to Health Care Service Corp. frees capital and allows Cigna to double down on commercial and employer‑sponsored plans, where it can leverage its Evernorth data‑analytics and AI capabilities. Recent financials show a near $6 billion net income for 2025, underscoring the resilience of its core portfolio despite rising claim costs. Evanko’s track record of “transformative innovation” suggests a push toward more personalized, technology‑enabled care models that could improve member outcomes while containing expenses.

Industry analysts view the move as a strategic realignment that could sharpen Cigna’s competitive edge against UnitedHealth, CVS Health’s Aetna, and Humana. By focusing on data‑driven solutions and expanding its commercial footprint, Cigna aims to capture higher‑margin employer groups and differentiate its offerings through AI‑powered personalization. Shareholders have responded positively, noting the continuity of leadership and clear growth roadmap. The next few years will test Evanko’s ability to translate strategic intent into market share gains, especially as health‑care costs continue to climb and regulators scrutinize pricing models.